The Swiss Group for Cancer Research is looking for mesothelioma patients to join a clinical study that will determine whether mesothelioma symptoms can be better controlled with the use of a new device.

The Electronic Tool for Monitoring Symptoms and Syndromes Associated with Advanced Cancer (called E-MOSAIC) is a small, handheld device that monitors and tracks symptoms. Developers of E-MOSAIC are hopeful that the device will improve communication between mesothelioma patients and their doctors. They also believe that the device will play a vital role in planning and assessing cancer treatments.

Dr. Florian Strasser of the Kantonsspital Hospital in Switzerland will be heading the study, which is expected to be completed by July 2010.

Source: Mesothelioma Patients Needed for New Clinical Trial

Share This